Stories > Eli Lilly Acquires Versanis Bio

Eli Lilly Acquires Versanis Bio

GLP-1 Agonists and Weight-Loss Drugs Dri...

GLP-1 Agonists: Impact and Rebound

Acquisition Progress Amid Safety Concern

Amgen's Obesity Prospects and Q4 Results...

Anti-Obesity Meds' Impact on Allurion Pr...